INTRODUCTION
============

Elevated levels of reactive oxygen species (ROS) are commonly observed during aging or in response to environmental stress. High ROS levels cause lipid oxidation, protein aggregation, and DNA damage ([@B39]), leading to activation of stress-response pathways ([@B21]). If the damage is too extensive, the cell will initiate the programmed cell death (PCD) pathway ([@B37]). An early step in the stress-response pathway is extensive mitochondrial fragmentation or fission ([@B9]). Several studies support a model that hyperfission helps facilitate mitochondrial outer membrane permeability, leading to release of proapoptotic factors and caspase activation ([@B55]).

In yeast and mammalian cells, cyclin C-Cdk8 regulates transcription through association with the RNA polymerase II holoenzyme (for a review, see [@B42]). The cyclin C-Cdk8 kinase controls transcription though modification of the basal transcriptional machinery ([@B1]), chromatin ([@B38]; [@B31]), or transcription factors ([@B25]; [@B41]). In addition to Cdk8p, cyclin C also associates with two additional proteins (Med12p and Med13p) in a complex termed the Cdk8 module ([@B4]). This module is highly conserved and is found either free ([@B30]) or associated ([@B13]) with the Mediator, a 25--30 protein complex that associates with the RNA polymerase II holoenzyme ([@B3]). Expression profiling revealed that components of this module control the expression of a similar subset of genes ([@B57]). However, the individual components have also been shown to have varying roles in transcriptional control during *Drosophila* development ([@B22]). In addition, Med12p, but not the other components of the module, is required for induction of the multidrug transporter *PDR5* in mitochondrial DNA--deficient (rho^0^) cells ([@B50]), indicating an important exchange of information occurs between these two organelles.

Recent studies have revealed an important second role for cyclin C that is independent of Cdk8p. In response to oxidative or ethanol stress, cyclin C, but not Cdk8p, translocates from the nucleus to the cytoplasm ([@B16]), where it interacts with the fission machinery to induce mitochondrial hyperfission ([@B14]). Consistent with a role for mitochondrial fission and PCD execution, loss of cyclin C function restricts fission ([@B14]) and enhances cell viability following stress ([@B32]). Conversely, aberrant localization of cyclin C in the cytoplasm induces stress-independent hyperfission and sensitizes the cell to oxidative stress ([@B14]). These results indicate that the decision to retain cyclin C in the nucleus or release it into the cytoplasm is an important regulator of PCD initiation. A previous study revealed that Cdk8p is required for normal cytoplasmic translocation of cyclin C ([@B16]), but the mechanism was unknown. Here, we provide evidence that Med13p plays the opposite role to Cdk8p by retaining cyclin C in the nucleus in unstressed cells. In response to stress, cyclin C release from Med13p requires the stress-activated MAP kinase Slt2p and Cdk8p activity. Aberrant cyclin C relocalization to the cytoplasm results in continuous mitochondrial fragmentation and dysfunction. These results indicate that Med13-cyclin C interaction is controlled by multiple signals to insure the proper subcellular localization of cyclin C in stressed and unstressed cells.

RESULTS
=======

Med13p is required for nuclear retention of cyclin C in unstressed cultures
---------------------------------------------------------------------------

In response to several types of stress, the transcription factor cyclin C translocates from the nucleus to the cytoplasm through a mechanism that requires Cdk8p ([@B16], [@B14]). Therefore we next determined whether the two remaining components of the Cdk8 module, Med12p and Med13p, also regulate cyclin C relocalization. Using fluorescence microscopy, we monitored the localization of a functional cyclin C--yellow fluorescent protein (cyclin C-YFP) reporter protein in *med12*∆ or *med13*∆ mutants before and following H~2~O~2~ stress application. In wild-type cells, H~2~O~2~ induces cyclin C translocation from the nucleus to the cytoplasm, where it interacts with the mitochondria to induce fission (see [@B14]; and [Figure 1A](#F1){ref-type="fig"}). Deleting *MED12* did not affect cyclin C nuclear localization in unstressed cells or stress-induced cytoplasmic relocalization (Supplemental Figure S1A). However, cyclin C-YFP formed multiple cytoplasmic foci in the unstressed *med13*∆ strain ([Figure 1B](#F1){ref-type="fig"}) similar to those observed in oxidatively stressed wild-type cells. In addition, these foci colocalized with fragmented mitochondria. These results indicate that Med13p is required for cyclin C retention in the nucleus of unstressed cells.

![Med13p retains cyclin C in the nucleus. (A) Subcellular localization of cyclin C (cyclin C-YFP), mitochondria (mt-DsRed), and nuclei (DAPI) were monitored by fluorescence microscopy in a wild-type cell (RSY10) before and following H~2~O~2~ treatment (1 mM) as indicated. (B) An unstressed *med13∆* culture (RSY1701) was examined as in A. (C) Representative image of mitochondrial morphology in *med13∆ cnc1∆* mutant (RSY1712, left panel) and quantitation of mitochondrial fission in cells with the indicated genotype (mean ± SEM, *n* ≥ 3). (D) Experiment described in B was repeated in unstressed *dnm1∆* (RSY1750) or *dnm1∆ med13∆* (RSY1894) mutant strains. DAPI staining was omitted in these experiments. Scale bar: 5 μM; h = hours.](2807fig1){#F1}

In addition to cyclin C mislocalization, we also observed that the mitochondria were highly fragmented in the *med13∆* mutant similar to what is observed in stressed wild-type cells (compare mt-DsRed panels in [Figure 1, A](#F1){ref-type="fig"} and [B](#F1){ref-type="fig"}, quantified in [C](#F1){ref-type="fig"}). We previously reported that the stress-induced cytoplasmic relocalization of cyclin C triggers extensive mitochondrial fission ([@B14]). Therefore we next determined whether the fragmented mitochondrial phenotype observed in the *med13∆* mutant was dependent on cyclin C. A *med13∆ cnc1∆* double mutant was constructed, and mitochondrial morphology was monitored in unstressed cultures. These experiments indicated that cyclin C is required for the hyperfission phenotype associated with the *med13∆* allele ([Figure 1C](#F1){ref-type="fig"}). Finally, we determined whether this fragmentation was dependent on Dnm1p, the dynamin-like GTPase required for fission ([@B48]). Similar to the *med13∆* strain, cyclin C-YFP exhibited cytoplasmic localization in the unstressed *dnm1∆ med13∆* double mutant ([Figure 1D](#F1){ref-type="fig"}). Although cyclin C could be observed associated with the mitochondria in the double mutant, the mitochondria retained their aggregated or net-like phenotype similar to the *dnm1∆* single mutant. These results are consistent with a model that the extensive mitochondrial fragmentation observed in a *med13∆* mutant requires cyclin C relocalization to the cytoplasm and Dnm1p activity.

Our previous work revealed that stress-induced relocalization to the cytoplasm triggers cyclin C proteolysis ([@B16]). Consistent with these results, cyclin C was destroyed more rapidly in *med13∆* mutants exposed to H~2~O~2~ stress (Figure S1B). This instability required the oxidative stress response, as glucose-repressible shutoff experiments revealed no significant difference in cyclin C stability in unstressed cells (Figure S1C). These results indicate that precocious cytoplasmic localization of cyclin C in itself is insufficient to induce its destruction. However, cytoplasmic cyclin C appears more rapidly targeted by a stress-activated destruction pathway.

Med13p regulates Cdk8p nucleolar localization
---------------------------------------------

Our previous studies ([@B16]) found that Cdk8p does not relocate to the cytoplasm in H~2~O~2~-treated cells. Rather, it colocalizes with the nucleolar marker Nop1p--red fluorescent protein (Nop1p-RFP) in response to oxidative stress ([Figure 2A](#F2){ref-type="fig"}). Therefore we next determined whether Med13p is required for Cdk8p nuclear localization and/or its stress-induced concentration in the nucleolus. To address this question, we monitored Cdk8p--green fluorescent protein (Cdk8p-GFP) localization in unstressed or stressed *med13∆* mutant cultures. In the unstressed *med13∆* culture, the Cdk8p-GFP signal exhibited a diffuse nuclear pattern similar to that observed in wild-type cells ([Figure 2B](#F2){ref-type="fig"}). However, Cdk8p-GFP also exhibited nucleolar localization in 78% (SEM ± 8, *n* = 3) of the unstressed *med13∆* cells ([Figure 2B](#F2){ref-type="fig"}, top panels). These observations suggest that Med13p normally prevents Cdk8p entry into the nucleolar compartment in unstressed cells. Following H~2~O~2~ treatment, Cdk8p-GFP and Nop1p-RFP colocalization still occurred in the *med13∆* cells. However, the overall Cdk8p-GFP signal also remained diffused over the nucleus rather than concentrating in the nucleolus as observed in wild-type cells. These results suggest a complicated role for Med13p in regulating Cdk8p subnuclear localization. In unstressed cells, Med13p prevents Cdk8p nucleolar localization. However, Med13p is also required for normal consolidation of Cdk8p in the nucleolus of stressed cells.

![Regulation of GFP-Cdk8p localization by Med13p. GFP-Cdk8p localization was monitored by fluorescence microscopy in the wild-type RSY10 (A) or *med13∆* mutant RSY1701 (B) strains before and 2 h after H~2~O~2~ addition as indicated. Nucleolar and nuclear locations were followed by Nop1p-RFP and DAPI signals, respectively. Arrows indicate cells that are enlarged in the zoom panels. Scale bar: 5 μM; h = hours.](2807fig2){#F2}

Med13p protects cells for H~2~O~2~-induced cell death
-----------------------------------------------------

Mitochondrial hyperfission is an early step in the stress response and is associated with PCD induction ([@B20]). Supporting this model, *cnc1∆* mutants fail to undergo stress-induced mitochondrial hyperfission ([@B14]) and are resistant to H~2~O~2~-induced PCD ([@B32]; [@B14]). Therefore we next examined the role of Med13p in regulating the cellular response to oxidative stress. Although extensive mitochondrial fragmentation is observed in unstressed *med13∆* cells, this event on its own did not induce cell death, as evidenced by the similar plating efficiency of unstressed wild-type and mutant cultures ([Figure 3A](#F3){ref-type="fig"}, top rows). However, *med13∆* cells demonstrated a hypersensitivity to H~2~O~2~ (second panel) compared with wild-type while *cnc1∆* strains (third panel) were resistant to this pro-oxidant. To determine whether this hypersensitivity was due to aberrant cyclin C localization, we repeated the experiment with a *med13Δ cnc1Δ* double mutant. Loss of cyclin C suppressed the H~2~O~2~ hypersensitivity associated with the *med13∆* allele ([Figure 3A](#F3){ref-type="fig"}, right panel) similar to levels observed for the *cnc1∆* allele alone. These results suggest that Med13p-dependent retention of cyclin C in the nucleus prevents hypersensitivity to H~2~O~2~. Finally, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays and flow-cytometry analyses indicated that the elevated cell death observed in stressed *med13∆* mutants corresponded to an increase in cells exhibiting positive TUNEL signal ([Figure 3B](#F3){ref-type="fig"}). As expected, TUNEL-positive cells were reduced in either the *cnc1∆* or *cnc1∆ med13∆* strains. Taken together, these results suggest that loss of Med13p function predisposes cells to programmed cell death through a cyclin C--dependent mechanism.

![Med13p is required for normal oxidative stress sensitivity. (A) Mid--log wild-type (RSY10), *med13∆* (RSY1701), *cnc1∆* (RSY391), and *cnc1∆ med13∆* (RSY1712) cultures were treated with the H~2~O~2~ concentrations as indicated for 2 h and then serially diluted (1:10) before being plated on rich growth medium. The plates were incubated 3 d before image collection. (B) TUNEL assays were performed on strains described in A that were treated with 2 mM H~2~O~2~ for 20 h. Typical histograms are shown depicting fluorescence-activated cell sorting analysis of untreated and treated samples as indicated. The numbers in the lower right of each panel indicate the percentage of the population exhibiting a TUNEL-positive signal (SEM \< 5%, *n* = 3).](2807fig3){#F3}

Med13p maintains mitochondrial DNA integrity
--------------------------------------------

Previous studies have implicated excessive mitochondrial fission with loss of mitochondrial function ([@B11]). These experiments were accomplished using knockdown or deletion of fusion machinery components. To ask this same question without altering the basic fission or fusion machinery, we monitored mitochondrial function in *med13∆* mutants, using growth on a respiratory-necessary carbon source (acetate) as the readout. These studies revealed that the *med13∆* mutant was not able to grow on acetate medium but displayed nearly normal growth rate in the presence of the fermentable carbon dextrose ([Figure 4A](#F4){ref-type="fig"}). This result indicates that Med13p is required for mitochondrial function, confirming the results of an earlier study ([@B50]). Next we examined whether loss of mitochondrial function was dependent on cyclin C. Double mutant experiments revealed that, similar to the stress hypersensitivity phenotype, deleting *CNC1* also suppressed the mitochondrial defect observed in *med13∆* mutants. These results suggest that the extensive mitochondrial fragmentation induced by aberrant cyclin C cytoplasmic localization is deleterious to mitochondrial function. For further exploration of this possibility, the *med13∆ dnm1∆* double mutant described earlier was assayed for mitochondrial function. Following approximately 90 generations in the presence of a fermentable carbon source, 97% (± 3, *n* = 4) of the double mutant cells were still respiration competent compared with \<5% for *med13∆* mutants. These results suggest, as others have reported, that continuous mitochondrial fission is deleterious to long-term maintenance of mitochondrial function.

![Med13p is required to maintain mitochondrial DNA integrity. (A) Mid--log cultures as described in [Figure 3](#F3){ref-type="fig"} with the indicated genotype were grown in dextrose medium and then serially diluted (1:10) before being plated on medium containing either dextrose or acetate as the sole carbon source. The plates were incubated 3 d before image collection. (B) Mitochondrial morphology and mtDNA abundance was monitored by mt-DsRed and DAPI staining, respectively, in wild-type (RSY10) and *med13∆* mutant (RSY1701) cells. Arrowheads indicate typical mtDNA nucleoids within the mitochondria in wild-type cells. Representative images of the three general phenotypic classes observed in the *med13∆* strain are shown with quantification. White arrows indicate normal overlapping mtDNA-mitochondrial signals; green arrows indicate abnormal nuclear morphology; red arrows indicate examples of fragmented mitochondria without a visual mtDNA signal; yellow arrows indicate DAPI staining signals that may represent nuclear fragmentation or aberrant mtDNA signals. (C) qPCR analysis of two mtDNA loci *COX1* and 21S rRNA in the strains indicated. Values are depicted relative to the single-copy *ACT1* locus. Results shown are the means (± SEM) from three biological replicates. Scale bar: 5 μM.](2807fig4){#F4}

Loss of mitochondrial function can be the result of mutations in either the mitochondrial or nuclear genome. In yeast, respiration-deficient cells can exhibit total loss of mitochondrial DNA (mtDNA), a condition termed Rho^0^. To determine whether *med13∆* mutants retained their mtDNA, we conducted 4′,6-diamidino-2-phenylindole (DAPI) staining followed by fluorescence microscopy. Wild-type cells exhibited small nucleoids throughout the mitochondrial continuum ([Figure 4B](#F4){ref-type="fig"}, arrowheads). In *med13∆* cells, three classes of mtDNA signals were observed. The predominant class 1 phenotype exhibited normal-appearing mtDNA signals associated with the mitochondria (white arrows). However, two additional classes were observed. Class 2 mutants displayed mtDNA-mitochondrial association but also exhibited abnormal nuclear morphology (green arrows). In addition, DAPI-staining signals were absent in a subset of the mitochondrial signals (red arrows). It is important to note that DAPI staining alone is not sufficient to conclude the absence of mtDNA, but rather only that the DNA signal is reduced. Finally, class 3 mutants display a more degraded nuclear DAPI signal with additional DAPI staining bodies not associated with the nucleus or the mitochondria (yellow arrows). Taken together, these results indicated that *med13∆* mutants retain mtDNA, although the amount of the DNA may be reduced.

To further characterize mtDNA integrity in *med13∆* mutants, we utilized quantitative real-time PCR (qPCR) to test for the presence of *COX1* and 21S rRNA alleles. Both alleles were quantitated using qPCR and then compared with a nuclear gene control (*ACT1*). The primers were chosen to generate relatively small amplicons (102 and 29 base pairs, respectively) to detect retention of discreet regions of the mitochondrial genome. In addition, these loci are on opposite sides of the mitochondrial genome. This experiment produced a calculated wild-type copy number of *COX1* and 21S rRNA at 28 and 29, respectively ([Figure 4C](#F4){ref-type="fig"}). This copy number is in the normal range for mtDNA ([@B54]). However, less than one copy of either locus was measured in the *med13∆* mutant. These results indicate that significant deletions of mtDNA occurred in the *med13∆* strain and support the model that excessive fission is deleterious to overall mitochondrial genome maintenance.

Med13p is destroyed in response to H~2~O~2~ stress
--------------------------------------------------

Our results are consistent with a model that disrupting cyclin C-Med13p association is important to release the cyclin into the cytoplasm in stressed cells. Therefore we next investigated whether Med13p regulation itself provided insight into how this interaction is dissolved. Initially, we monitored Med13p localization in the cell expressing an endogenously tagged functional *MED13-*YFP allele. As expected, fluorescence microscopy revealed that Med13p-YFP displayed diffuse nuclear staining in unstressed cells (Figure S2). Following 1-h H~2~O~2~ treatment, no difference in Med13p-YFP localization was noted, indicating that relocalization of this factor is not a primary regulatory mechanism. Next we examined Med13p levels in an H~2~O~2~-stressed culture expressing an endogenously tagged *MED13* allele (13-myc). Western blot analysis revealed a dramatic reduction in Med13p levels following stress application ([Figure 5A](#F5){ref-type="fig"}, left panel). Med13p-myc reduction was due to enhanced degradation and not translation inhibition, as Med13p is relatively stable as determined by translation inhibition experiments in unstressed cells (right panel). Thus Med13p is actively targeted for degradation during oxidative stress. To determine whether Med13p destruction required the 26S proteasome, we repeated this experiment in a strain deleted for *UMP1*, a gene whose product is required for 20S proteasome maturation ([@B44]). In response to H~2~O~2~ stress, Med13p-myc was protected from destruction in the *ump1∆* mutant compared with the wild-type control ([Figure 5B](#F5){ref-type="fig"}). These results indicate that Med13p destruction is most likely directed by a ubiquitin-mediated mechanism.

![Med13p is destroyed in response to oxidative stress. (A) Western blot analysis of endogenously tagged Med13p-13myc (RSY17896) during an H~2~O~2~ time-course experiment (left panel). Med13p-13myc turnover rate was monitored in an unstressed log phase culture following the addition of cycloheximide (CHX, right panel). For all panels, "con" indicates the untagged parental strain (RSY10) controlling for nonspecific α-myc cross-reactivity. Pgk1p levels were used as loading controls. (B) Med13p-13myc levels were monitored by Western blot analysis during H~2~O~2~ stress time course in wild-type (RSY1786) and *ump1∆* (RSY1961) strains as described in (A). (C) Med13p-myc levels were monitored by Western blot in extracts prepared from a wild-type (RSY1786) or *cnc1∆* (RSY1930) strains before and following H~2~O~2~ treatment. (D) Med13p-13myc levels were monitored by Western blot analysis during H~2~O~2~ stress time course in *cnc1∆* strain (RSY1930) harboring the cyclin C^HAD∆^ expression plasmid pBK217. h = hours.](2807fig5){#F5}

To determine whether cyclin C is involved in H~2~O~2~-induced Med13p destruction, we monitored Med13p-myc levels in stressed *cnc1∆* mid--log cultures. Similar to *ump1∆* strains, Med13p-myc levels remained elevated in the *cnc1∆* mutant following H~2~O~2~ addition. These results indicated that cyclin C is required for Med13p turnover in stressed cells. We have previously demonstrated that a domain at the amino terminal end of cyclin C, the [h]{.ul}oloenzyme [a]{.ul}ssociation [d]{.ul}omain, or HAD ([@B17]), is required for Med13p association ([@B14]). Therefore we next examined whether cyclin C association per se was necessary for Med13p destruction. A *cnc1∆* strain was transformed with a plasmid expressing cyclin C with a small internal deletion of 10 amino acids in the HAD (HAD∆). In response to H~2~O~2~ exposure, Med13p destruction was also prevented in cells expressing cyclin C^HAD∆^ ([Figure 5D](#F5){ref-type="fig"}). These results indicate that oxidative stress--induced Med13p destruction required the proteasome and cyclin C association.

Med13p destruction is mediated by Cdk8p activity
------------------------------------------------

The requirement of cyclin C for Med13p destruction suggested a role for Cdk8p in this process. Therefore we next monitored Med13p levels in a *cdk8∆* mutant expressing a kinase-dead *cdk8* allele (*cdk8^KD^*; [@B53]). Similar to the *cnc1∆* mutant, Med13p was protected from destruction in the strain expressing the kinase-dead allele ([Figure 6A](#F6){ref-type="fig"}). These results indicate that Cdk8p kinase activity is required for Med13p destruction. We next examined the impact that loss of Cdk8p kinase activity had on cyclin C localization. A *cdk8∆*-null strain expressing either wild-type or the kinase-dead allele of *CDK8*, along with cyclin C-YFP, was subjected to H~2~O~2~ stress (0.8 mM) for 2 h; this was followed by fluorescence microscopy. As expected, the strain expressing wild-type *CDK8* exhibited normal cyclin C-YFP relocalization to the cytoplasm ([Figure 6B](#F6){ref-type="fig"}, top panels). Conversely, cyclin C-YFP formed a single focus associated with the nuclear periphery (bottom panels). This observation is similar to our previous study, which found nucleolar targeting of cyclin C-YFP in stressed *cdk8∆* cells ([@B14]). These results are consistent with a model that Med13p destruction is required for cyclin C translocation from the nucleolus to the cytoplasm.

![Med13p destruction requires Cdk8p activity. (A) Med13p-13myc levels were monitored in an H~2~O~2~ (0.8 mM) stressed mid--log *cdk8∆* strain (RSY1954) expressing the wild-type *CDK8* (pPL144-21) or a kinase-dead derivative (pPL144-23). Pgk1p levels were used as a loading control. (B) Localization of cyclin C-YFP in wild-type or Cdk8p^KD^-expressing cells following 2 h treatment with H~2~O~2~ (0.8 mM). Subnuclear localization of cyclin C-YFP in the *cdk8^KD^*-expressing cells is indicated by the arrowheads. The Normoski (Nom.) and nuclear (DAPI) images are indicated. (C) Endogenously tagged Med13p-3 hemagglutinin (HA) levels were monitored in an unstressed wild-type strain (RSY1788) harboring constitutively active *RHO1* (*RHO1^G19V^* or *RHO1^Q68L^*) expression plasmids. Protein extracts were immunoprecipitated with HA monoclonal antibodies, and the immunoprecipitates were probed for the presence of Med13p-HA. The parental strain (con) and no antibody controls are shown. Tub1p levels were monitored as a loading control. (D) Cyclin C^S266A^-YFP localization was monitored in unstressed *cnc1∆* (RSY391) or *cnc1∆ med13∆* (RSY1712) strains. The Normoski (Nom.) and nuclear (DAPI) images are indicated. (E) Coimmunoprecipitation studies were conducted in extracts prepared from a wild-type strain expressing Med13p-myc (RSY1786) and either cyclin C-YFP (pBK38) or cyclin C^S266E^-YFP (pBK53). α-myc or α-GFP immunoprecipitates were probed for the presence of cyclin C-YFP (E) or Med13p-myc (F) as indicated. Open brackets indicate the no immunoprecipitation antibody controls. GFP lanes contain extracts prepared from cells expressing only GFP (pUG36) to control for interaction of GFP alone with Med13p-myc. Scale bar: 5 μM; h = hours.](2807fig6){#F6}

Med13p destruction and cyclin C translocation are controlled by separate signaling pathways
-------------------------------------------------------------------------------------------

Modification of cyclin C on Ser-266 by the cell wall integrity (CWI) MAP kinase Slt2p/Mpk1p is required for normal cyclin C translocation in response to H~2~O~2~ stress ([@B28]). This MAP kinase module is stimulated by Rho1p through protein kinase C (Pkc1p; for a review, see [@B34]). To determine whether Med13p stability is controlled by the CWI pathway, we monitored the levels of Med13p-myc in unstressed cultures harboring plasmids expressing wild-type *RHO1* or one of two constitutively active alleles (Q68L or G19V; [@B47]). Our previous studies found that the presence of activated Rho1p was sufficient to induce cyclin C relocalization and destruction in the absence of stress ([@B28]). Western blot analysis revealed that Med13p-myc levels were not altered in the presence of the activated *RHO1* alleles ([Figure 6C](#F6){ref-type="fig"}). These results indicate that Slt2p activity is not sufficient to drive Med13p destruction. These results raised the question of the relationship between cyclin C phosphorylation and Med13p destruction with respect to cyclin C release from the nucleus. To address this question, we used a Ser-266 to alanine (S266A) mutant form of cyclin C that prevents Slt2p phosphorylation and its subsequent relocalization to the cytoplasm under low-stress conditions ([@B28]). Localization of cyclin C^S266A^-YFP was monitored in unstressed *cnc1∆* and *cnc1∆ med13∆* mutants. Although nuclear in the wild-type strain, we found cyclin C^S266A^ in the cytoplasm in the *med13∆* mutant ([Figure 6D](#F6){ref-type="fig"}). These results indicate that *med13∆* is epistatic to cyclin C^S266A^ and formally implies that Med13p function is either downstream or independent of Ser-266 phosphorylation.

To further test this model, we conducted coimmunoprecipitation experiments between Med13p and either cyclin C or cyclin C^S266E^. This substitution mutation mimics cyclin C phosphorylation and allows partial release of cyclin C into the cytoplasm ([@B28]). Extracts were prepared from mid--log cultures (no stress) expressing Med13p-myc and either cyclin C-YFP or cyclin C^S266E^-YFP. These samples were immunoprecipitated with either α-GFP or α-myc antibodies, and then the immunoprecipitates were subjected to Western blot analysis probing for the presence of cyclin C-YFP or cyclin C^S266E^-YFP. This experiment revealed a reduction cyclin C^S266E^-YFP able to immunoprecipitate with Med13p-myc (compare lanes 6 and 7, [Figure 6E](#F6){ref-type="fig"}). No significant differences were observed in cyclin C or cyclin C^S266E^ levels (lanes 2 and 3). In addition, this interaction was independent of the YFP tag (lane 5) and required the myc antibody (lane 8). When the coimmunoprecipitation was examined by probing for the presence of Med13p-myc, a similar result was obtained. The substitution mutation was again less able to interact with Med13p-myc (compare lanes 2 and 3, [Figure 6F](#F6){ref-type="fig"}). These results indicate that cyclin C^S266E^ reduces but does not eliminate Med13p association. In addition, these results provide a mechanism for the requirement of Slt2p in mediating cyclin C relocalization to the cytoplasm. Taken together, our results support a two-step system controlling cyclin C-Med13p association and, ultimately, cyclin C nuclear retention or release.

DISCUSSION
==========

In unstressed cells, cyclin C and Cdk8p form a complex with two additional proteins (Med12p and Med13p) that associates with the Mediator to control gene transcription. In response to stress, cyclin C translocates from the nucleus to the cytoplasm, where it promotes both mitochondrial fragmentation and PCD. Therefore the switch governing cyclin C retention or release from the nucleus is an important cell fate discriminator. In this paper, we demonstrate that Med13p is responsible for retaining cyclin C in the nucleus in unstressed cells. Deleting *MED13* releases cyclin C into the cytoplasm, inducing extensive mitochondrial fission, oxidative stress hypersensitivity, and loss of mtDNA integrity. Our previous studies revealed that cyclin C relocalization requires Cdk8p and activation of the CWI pathway. We now provide mechanisms to explain the requirement of each factor. We found that Med13p is destroyed in response to oxidative stress in a manner dependent on Cdk8p activity. In addition, our data indicate that Slt2p-dependent phosphorylation of cyclin C helps destabilize its interaction with Med13p. Taken together, these data reveal that Med13p maintains mitochondrial function and protects the cells from aberrant PCD execution through retention of cyclin C in the nucleus.

We find that loss of Med13p activity results in extensive mitochondrial fragmentation in unstressed cells. In light of our previous report ([@B14]) and results from the present study, release of cyclin C into the cytoplasm is responsible for this dramatic fission phenotype. Two additional phenotypes associated with the *med13∆* allele include H~2~O~2~ hypersensitivity and loss of mitochondrial function. The respiration dysfunction could be caused by mutation within mitochondrial genome or misexpression of a nuclear gene caused by the *med13∆* allele. Several results indicate that the respiration deficiency in *med13Δ* mutant is due to mtDNA defect and not the transcriptional role of Med13p. First, we quantified a significant loss in two mtDNA loci in *med13∆* strains. Second, dissection of *MED13/med13* diploids resulted in spores exhibiting both active and inactive mitochondria. However, the mitochondrial defective phenotype did not cosegregate with the *med13* mutant allele. Finally, studies in mice ([@B12], [@B11]; [@B2]) and yeast ([@B24]; [@B49]) have reported that the inability to undergo fusion causes elevated mtDNA damage. These data argue that aberrant mitochondrial fission induced by constitutive cytoplasmic cyclin C localization accelerates loss of active mitochondria. An alternative explanation that we cannot rule out is that a transcriptional defect associated with loss of Med13p function reduces the efficiency of mitochondrial maintenance. Therefore, unlike nuclear petite mutants that display instant loss of mitochondrial activity, *med13∆* mutants may undergo an overall degradation of mitochondrial function that is manifested only after many generations. However, our finding that *dnm1∆* alleles are able to suppress the loss of mitochondrial function in a *med13∆* strain argues against this possibility. Additional studies into the exact role of cyclin C in promoting mitochondrial fission may help distinguish between these possibilities.

The second phenotype we observed is oxidative stress hypersensitivity. This observation may also be related to the impact of constant mitochondrial fragmentation. Many studies have observed that mitochondrial fragmentation is an early step in the stress-response pathway (for reviews, see [@B46]; [@B55]). Consistent with this connection, we have previously demonstrated that cells lacking cyclin C fail to undergo fission and are resistant to oxidative stress ([@B14]). Studies in mammalian cells have found that the proapoptotic BH-3 family member Bax is recruited to sites of fission ([@B29]; [@B56]; [@B8]; [@B6]). Therefore it is possible that the constitutive recruitment of the fission machinery to the mitochondria by cyclin C may elevate the efficiency by which BH-3 proteins can induce PCD. In yeast, a BH-3 protein (Ybh3p) has been identified ([@B7]). Currently, studies are underway to determine the relationship between the stress hypersensitivity associated with *med13∆* alleles and Ybh3p activity.

This study and our previous work have identified two domains, the HAD and Ser-266 region, as sites controlling cyclin C nuclear localization. Structural analysis of the *Saccharomyces pombe* cyclin C provides a clue as to how these domains act together. Cyclins contain a repeat of the cyclin box fold, a five alpha-helix bundle ([@B26]). The amino cyclin box universally binds its cognate Cdk, while a role for the second cyclin box remains elusive. In addition, all cyclins possess an amino terminal helix of varying length that appears to have different functions. For cyclin A, the amino terminal helix folds back on itself to make contact with Cdk2 ([@B27]). Conversely, this region in cyclin C contains the HAD (see [Figure 7A](#F7){ref-type="fig"}) and has been described as flexible ([@B26]) or more rigid ([@B45]). Previously, we demonstrated that the hydrophobic residues in this domain (indicated by yellow coloring), as well as its alpha-helical nature, are required for HAD function ([@B17]). In addition, the cyclin C HAD mutant is less able to coimmunoprecipitate with Med13p, causing partial release from the nucleus and an intermediate, mixed fusion--fission phenotype, in unstressed cells ([@B14]). Similarly, another study demonstrated that a phosphomimetic substitution mutation at Ser-266 (S266E) also displays a reduced ability to associate with Med13p and causes a partial release of cyclin C from the nucleus ([@B28]). These results suggest a common role for these domains. The solved cyclin C structure ([@B26]) allowed us to model Ser-266 to the loop region between the third and fourth helix of the second cyclin box ([Figure 7A](#F7){ref-type="fig"}). Interestingly, both the HAD and Ser-266 regions are on the same side of cyclin C, raising the possibility that they represent a docking site for Med13p, as previously suggested ([@B26]). Therefore combining our genetic results with the crystal data suggests that the HAD and Ser-266 regions form a protein-binding domain on cyclin C away from Cdk8p interaction. Consistent with this model, the crystal structure also predicts a hydrophobic pocket ([Figure 7A](#F7){ref-type="fig"}, light blue region) that may facilitate protein:protein interaction.

![Models for Med13p control of cyclin C subcellular localization. (A) RasMol-generated images of the cyclin C crystal structure solved by [@B26]). A space-filling (left) and ribbon (right) diagram with the HAD (yellow), Ser-266 (dark red), and the hydrophobic pocket (light blue) imposed on the cyclin C structure. The ribbon diagram is rotated 90° with respect to the space-filling model. The cyclin box region that binds Cdk8p is on the other side of the space-filling model. The Ser-266 region is approximate, as the loop region in which it resides was not modeled. (B) Model for regulation of cyclin C release from Med13p. Proposed interaction of Med13p with the cyclin box II region is depicted with the HAD and Ser-266 region as indicated. Activation of the CWI MAP kinase Slt2p results in phosphorylation of cyclin C on Ser-266, causing partial disruption of this interaction. Phosphorylation by Cdk8p makes Med13p susceptible to ubiquitin-mediated proteolysis, resulting in complete release of cyclin C into the cytoplasm.](2807fig7){#F7}

Our finding that cyclin C is cytoplasmic in unstressed *med13∆* mutants indicates that the system controlling cyclin C translocation does not require a stress signal. Therefore Med13p release appears to be the critical decision point in controlling cyclin C localization. We have recently demonstrated that the CWI MAP kinase Slt2p phosphorylates Ser-266 ([@B28]) and that this modification is required for efficient cyclin C cytoplasmic translocation. Therefore cyclin C phosphorylation reduces its ability to bind Med13p ([Figure 7B](#F7){ref-type="fig"}). To relieve HAD binding, Med13p is destroyed, which commits the cell to cyclin C release. Interestingly, the CWI signal transduction pathway that mediates cyclin C phosphorylation is not involved in Med13p proteolysis, indicating the existence of another pathway triggering this process. Indeed, Med13p is a known substrate of the protein kinase A signal transduction pathway ([@B10]). We found that cyclin C and Cdk8p kinase activities are required for Med13p destruction. As a previous study found that mammalian Med13 is a substrate of Cdk8 ([@B31]), the interaction we observe may be direct. In addition, a recent study found that Cdk8 phosphorylation induced the destruction of the Mediator component Med3 ([@B23]). Finally, similar to our results, steady-state turnover of mammalian Med13 is mediated by a ubiquitin-mediated process ([@B19]). Taken together, our findings are consistent with a model that stress-activated destruction of Med13p requires phosphorylation by Cdk8p. This possibility implies that activation of two separate pathways is required for full release of cyclin C. It is reasonable to expect that cyclin C translocation to the cytoplasm is tightly controlled to prevent aberrant mitochondrial fission and/or elevated sensitivity to stress, two outcomes that are deleterious to cell fitness.

MATERIALS AND METHODS
=====================

Yeast strains and plasmids
--------------------------

All *Saccharomyces cerevisiae* strains used in this study are derivatives of a W303-1A variant ([@B52]) and are listed in [Table 1](#T1){ref-type="table"}. In accordance with the gene nomenclature standardization efforts ([@B5]), *CNC1* (a.k.a. *SSN3*/*SRB11*/*UME3*), *MED12* (a.k.a. *SRB8*/*SSN5*), *MED13* (a.k.a. *SSN2*/*SRB9*/*UME2*), and *CDK8* (*SSN8*/*SRB10*/*UME5*) gene designations will be used. Gene deletions were constructed as described previously ([@B35]). The *med13Δ cnc1Δ* strain (RSY1712) was generated by deleting *MED13* in the *cnc1∆* mutant RSY391. The endogenous *MED13*-yECitrine::KanMx6 construct was made using pKT140 ([@B51]). The strain containing the integrated *CNC1-TAP* allele (RSY1010) was a gift from Nynke L. van Berkum. Plasmids pKC337, pKC333, and pBK37 were described previously ([@B15], [@B16]). pBK217 containing the *CNC1^HAD∆^* allele was previously described ([@B14]). Mitochondria visualization was achieved using pMt-DsRed (a gift from J. Nunnari; [@B40]). Plasmids pUG36 (MET25-GFP control), pBK38 (cyclin C-YFP), and pBK53 (cyclin C^S266E^-YFP) have been previously described ([@B43]; [@B28]). The *CDK8/SSN8/SRB10* (pPL144-21) and *cdk8^KD^* (pPL144-23) expression plasmids have been previously described ([@B53]). The G19V (pYO964) and Q68L (pYO965) constitutively active *RHO1* expression plasmids ([@B47]) were a gift from Y. Ohya. A *ump1* mutant strain ([@B44]) used to generate RSY1961 was a gift from R. J. Dohmen.

###### 

*S. cerevisiae* strains.

  Strain    Genotype                                                                     Source
  --------- ---------------------------------------------------------------------------- ------------
  RSY10                                                                                  [@B52]
  RSY391    *cnc1::LEU2*                                                                 [@B15]
  RSY392    *cnc1::TRP1*                                                                 [@B15]
  RSY1701   *med13::HIS3*                                                                This study
  RSY1712   *cnc1::LEU2 med13::HIS3*                                                     This study
  RSY1786   *MED13-13myc::KanMX6*                                                        This study
  RSY1812   *MED13--yECitrine::KanMX6*                                                   This study
  RSY1961   *his3∆ leu2-3112 lys2-801 trp1-∆63 ura3-52 ump1::HIS3 MED13-13myc::KanMX6*   This study
  RSY1930   *cnc1::LEU2 MED13-13myc::KanMX6*                                             This study
  RSY1700   *med12::HIS3*                                                                This study
  RSY1750   *dnm1::KanMX6*                                                               This study
  RSY1894   *dnm1::KanMX6 med13::HIS3*                                                   This study
  RSY1954   *cdk8::his5+ cnc1::LEU2 MED13-13myc::KanMX6*                                 This study
  RSY1788   *MED13-3HA::KanMX6*                                                          This study
  RSY1861   *KanMX6-GAL1~pro~-GFP-CDK8*                                                  This study
  RSY1863   *KanMX6-GAL1~pro~-GFP-CDK8 med13::HIS3*                                      This study

All strains are derived from the W303 background and contain the genotype *MAT***a** *ade2 ade6 can1-100 his3-11,15 leu2-3112 trp1-1 ura3-1*, except RSY1961.

Growth and stress assays
------------------------

Cells were grown in either rich, nonselective medium (YPDA) or synthetic minimal medium (SC) allowing plasmid selection as previously described ([@B15]). Clonogenic viability studies were conducted with mid--log phase (6 × 10^6^ cells/ml) treated with 1 or 2 mM H~2~O~2~ for 2 h and then serially diluted (1:10) and plated on the nonselective medium (YPDA). TUNEL assays were conducted essentially as previously described ([@B36]; [@B32]). TUNEL-positive cells were measured by fluorescence-activated cell analysis using the Accuri C6 cell analyzer. All statistical analysis was performed using the Student\'s *t* test with *p* \< 0.05 considered significant. All analyses were conducted with at least three independent cultures with 300 or more cells counted per time point. Quantitative PCR analysis of mtDNA loci was accomplished using Taqman cybergreen method (Applied Biosystems, Grand Island, NY). The threshold cycle number (C~T~) values were normalized to the nuclear *ACT1* locus. COX1-F-5′-CTACAGATACAGCATTTCCAAGA; COX1-R-5′-GTGCC­TG-AATA­GATGATAATGGT; 21S-F-5′-AATTGA­CCCG­AAA­GC­AAACG' 21S-R-5′-TTGCAACAT-CAACCTGTTCGA; ACT1-F-5′-GTATGTGTAAAGCC­GGTTTTG; ACT1-R-5′-CATGATA­CCT-TGGTGT­CTTGG

Microscopy and cell analysis
----------------------------

Intracellular localization studies of chimeric fusion proteins were performed in fixed or living cells as indicated in the figure legends. Cells were fixed in 3.7% paraformaldehyde and stained with DAPI, as previously described ([@B18]). For all experiments, the cells were grown to mid--log (5 × 10^6^ cells/ml), treated with 1 mM H~2~O~2~ for the time indicated in the text, and then analyzed by fluorescence microscopy. Images were obtained using a Nikon microscope (model E800) with a 60× objective (Plan Fluor Oil, NA 1.3) and a CCD camera (RETIGA Exi). Data were collected using Autoquant and processed using Image Pro software. All images were obtained using the same exposures for the course of the experiment.

Western blot analysis
---------------------

Straight Western blot analysis was performed as previously described ([@B33]) using 20 ml of mid--log phase cells per sample. For immunoprecipitations, protein extracts were prepared from mid--log phase cultures using mild RIPA buffer (150 mM NaCl, 1% NP-40, 0.15% doxycycline, 50 mM Tris-HCl, pH 8) and glass bead lysis, as described previously ([@B15]). Protein turnover rates were determined in mid--log phase (5 × 10^6^ cell/ml) cultures treated with cycloheximide (10 mg/l). Coimmunoprecipitation analyses were performed using 500 μg whole-cell extracts. Immunoprecipitations were conducted overnight at 4°C with agitation. Then protein complexes were bound to protein G-agarose beads (Roche, Indianapolis, IN) and processed according to the manufacturer\'s manual. GFP polyclonal antibody (Living Colors; Clontech, Mountain View, CA) or anti--c-myc monoclonal (9E10) antibody (Roche) was used for immunoprecipitations and Western blot analysis. The 12G10 mouse monoclonal anti-Tub1p antibody (Developmental Studies Hybridoma Bank, University of Iowa) and 3-phosphoglycerate K (Pgk1p) mouse immunoglubulin G1 (IgG1) monoclonal (22C5D8) antibody (Invitrogen) were used to detect Tub1p and Pgk1p, respectively, as loading controls in this study. Western blot signal was detected using alkaline phosphatase--conjugated goat anti-mouse IgG (H+L) or anti-rabbit IgG (H+L) (Jackson Laboratories, Bar Harbor, ME) and the CDP-Star chemiluminescence reagent (Tropix, Life Technologies, Grand Island, NY).
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CWI

:   cell wall integrity

DAPI

:   4′,6-diamidino-2-phenylindole

GFP

:   green fluorescent protein

HAD

:   holoenzyme association domain

IgG

:   immunoglubulin G

mtDNA

:   mitochondrial DNA

PCD

:   programmed cell death

RFP

:   red fluorescent protein

ROS

:   reactive oxygen species

YFP

:   yellow fluorescent protein
